Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In India
Dr Reddy’s To Launch New Treatment Options For Covid-19 In Next Few Months: MD
Sputnik V To Hit Indian Markets By May End As States, Hospitals Negotiate With Dr Reddy's Lab For Procurement
Single-Dose Sputnik Light Covid-19 Vaccine With Efficacy Of Nearly 80 Per Cent Authorised For Use In Russia
Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In India
India To Start Receiving Sputnik V Vaccine Shots This Quarter, Production In India To Start From July
Dr Reddy's Gets Indian Drug Regulator's Nod For Phase-3 Trials Of Russian Sputnik V Covid-19 Vaccine In India
